# Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis

> **NCT00069186** · PHASE3 · UNKNOWN · sponsor: **The Avicena Group** · enrollment: 107 (—)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **DRUG:** Creatine Monohydrate

## Key facts

- **NCT ID:** NCT00069186
- **Lead sponsor:** The Avicena Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 107 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00069186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00069186, "Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00069186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*